Sachs Jessica 4
4 · Cogent Biosciences, Inc. · Filed Feb 2, 2021
Insider Transaction Report
Form 4
Sachs Jessica
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-01+400,000→ 400,000 totalExercise: $9.10Exp: 2031-02-01→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest over a four year period as follows: 1/4th of the option shall vest one year after the vesting start date; then 1/48th of the option shall vest monthly over the remaining three year period.